US Broker Ratings

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 68% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has been capturing the attention of investors with its promising outlook in the biotechnology sector. The company, headquartered in Coral Gables, Florida, is dedicated to..

Metsera, Inc. (MTSR) Stock Analysis: Discover the 4.78% Upside Potential in the Biotechnology Sector

Metsera, Inc. (NASDAQ: MTSR) is making waves in the biotechnology sector with its innovative approach to combating obesity and related diseases. As a clinical-stage company based in New York, Metsera..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Exploring the 72.52% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, presents an intriguing opportunity for investors keen on the healthcare industry. With a current market capitalization of $3.65..

Haemonetics Corporation (HAE) Stock Analysis: A Closer Look at Growth Potential Amid Market Volatility

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector specializing in medical devices, has recently caught the attention of investors. With a market capitalization of $2.42 billion, this..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 61% Potential Upside Amid Solid Dividend Yield

Perrigo Company plc (PRGO) stands at a pivotal intersection for investors seeking opportunities in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With its current..

ACADIA Pharmaceuticals (ACAD): Investor Outlook on Potential 43.78% Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, is garnering significant investor attention owing to its focus on developing treatments for central nervous system (CNS) disorders..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Look at Its 49% Revenue Growth and Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing investment opportunity within the healthcare sector, particularly in the specialized industry of healthcare plans. This Orange, California-based company operates a consumer-centric platform..

Arcellx, Inc. (ACLX) Stock Analysis: A Promising Biotech Play with Significant Upside Potential

For investors with a keen interest in the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents an intriguing opportunity. As a healthcare company specializing in innovative immunotherapies, Arcellx is making strides..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 20% Upside Potential in Biotech

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is making waves with its innovative approach to treating serious metabolic diseases. Headquartered in South San Francisco, California,..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 36.85% Potential Upside in Innovative RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. Based in San Diego, California, Avidity is focused on delivering antibody..

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking a Potential 45% Upside in Biotech

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors seeking opportunities in the dynamic biotechnology sector. With a robust pipeline of therapies targeting central nervous system (CNS) disorders,..

Elanco Animal Health (ELAN) Stock Analysis: Growth Potential and Market Dynamics

Elanco Animal Health Incorporated (NYSE: ELAN) stands at the crossroads of innovation and animal welfare. With a market capitalization of $9.82 billion, this healthcare sector player is making strides in..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 57% Potential Upside Amidst Healthcare Innovations

In the dynamic realm of healthcare, Lantheus Holdings, Inc. (NASDAQ: LNTH) emerges as a compelling player, particularly for investors seeking opportunities in the specialty and generic drug manufacturing sector. With..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 72.68% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pivotal player in the healthcare sector, particularly within the medical devices industry, is catching the eye of investors with a promising potential upside..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 6.84% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the ophthalmic industry, has long been a beacon for innovation in eye health. With a market capitalization of $5.08 billion, the..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing investor attention due to its promising drug pipeline and notable upside potential. With a focused approach..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Powerhouse with 17% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, specializing in the treatment of rare neuroendocrine diseases. With its lead product, IMCIVREE (setmelanotide), Rhythm is making..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Healthcare Tech Landscape with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York, is garnering attention in the healthcare sector with its innovative approach to health plans and technology solutions...

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 99.86% Upside in the Biotech Space

ADMA Biologics Inc. (NASDAQ: ADMA), a prominent player in the biotechnology sector, has been capturing investor attention with its promising market position and growth potential. The company is committed to..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 38% Upside Potential with Robust Analyst Support

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, has been attracting considerable attention from investors due to its significant growth potential and strong pipeline of pharmaceutical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds